BiotechTube
Home/Cyted Health/Marcel Gehrung, PhD
MG

Marcel Gehrung, PhD

Co-founder & Chief Executive Officer

Cyted Health

Therapeutic Areas

Gastrointestinal OncologyGastroenterology

Cyted Health Pipeline

DrugIndicationPhase
EndoSign® for Barrett's Esophagus / Esophageal NeoplasiaDetection and risk stratification of Barrett's Esophagus and early esophageal neoplasiaCommercial
BEST4 Screening TrialLarge-scale randomized controlled trial for population screening of Barrett's EsophagusClinical Trial
Cytoprime2 Community Care StudyEffectiveness of EndoSign® in community care settings for early esophageal cancer detectionClinical Trial

Leadership Team at Cyted Health

PR
Prof. Rebecca Fitzgerald, FMedSci OBE
Co-founder & Clinical Advisor
BH
Betsy Hanna
President & US General Manager
DM
Dr. Maria O’Donovan, MB BCH, MD, FRCPath
Co-founder & Lead Pathologist
RH
Richard Hardwick, MD FRCS
Medical Director
View full Cyted Health profile